Project Grant R21EB036699
- This $300,000 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development of interpretable machine learning tools to uncover imaging biomarkers associated with breast and lung cancer. The project aims to create dimension reduction techniques to visualize features from deep learning models, establish an interpretable...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded a $1,535,084 Project Grant to Glimpse Diagnostics, Inc. to develop an artificial intelligence (AI) algorithm for diagnosing ear disease in young children. The project aims to 1) test the algorithm's performance on images of children with ear pain, and 2) demonstrate healthcare providers' ability to...
- The Children's Hospital Corporation, doing business as Boston Children's Hospital, received a $1,225,812 project grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program. The grant aims to develop rapid, robust, and accurate methods for reconstructing coherent 3D fetal brain volumes from 2D MRI slice stacks, and to integrate these...
- The U.S. National Cancer Institute (NCI) awarded a $1,073,736 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to Rivanna Medical, Inc. to develop an AI-assisted, ultrasound-based interventional guidance platform to reduce traumatic lumbar puncture (LP) rates in pediatric oncology patients. The key innovations for this medical device include imaging algorithms that highlight anatomical landmarks, automated injection site selection, a novel dual-array...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $306,463 Project Grant under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program to Dogpatch Medical LLC, effective September 1, 2025 through August 31, 2026. The grant funding supports the development of PASSIVECATH, an innovative microcatheter device designed for enhanced visibility and targeted drug delivery to the central nervous system...
- This $1,336,000 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program supports the development of a rapid, motion-robust, and low-gadolinium MRI technology for pediatric brain tumors. The key objectives are to (1) develop cutting-edge technologies for rapid, motion-robust, and quantitative MRI scans to reduce sedation needs...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $502,841 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program to The Regents of the University of California, operating as Lawrence Berkeley National Laboratory (LBNL). The funding will support research and development of a novel detector readout concept for monolithic scintillation detectors that enables direct digitization...
- The federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop an automated, nursing-informed solution to improve early detection of pressure injuries (PIs) using thermal imaging (thermography). The $598,617 award to Emory University will collect and validate a robust dataset of thermal and optical images from over...
- This Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development and validation of a novel technique called Synthetic Nephrographic Phase Images in CT (SNICT). The SNICT technique uses deep learning image processing to reconstruct nephrographic phase images from non-contrast and urographic phase CT data,...
- This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), is supporting the development of novel minimally invasive catheter-based devices for endovascular filtration. The goal is to remove chemotherapy drugs from the blood in order to reduce systemic toxicity during locoregional infusion therapy. The $670,440 award, granted on May 21,...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $642,000 to develop an automated assessment pipeline for evaluating peripherally inserted central catheters (PICCs) in pediatric chest radiographs using deep learning algorithms. The goal is to create an accurate, robust, and clinically available tool to automatically assess PICC position in pediatric patients, addressing the critical unmet need for such a system. The 3-year project, from August 2025 to July 2028, will be carried out by Children's Hospital Medical Center, a prominent non-profit pediatric hospital and research institution in Cincinnati, Ohio. The automated PICC assessment pipeline will closely mimic the steps radiologists take to identify PICC lines, locate the ideal landing zone, and determine proper tip positioning, with the aim of transforming PICC assessment through advanced AI-powered technology.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $642.0k | 8/13/25 |